New patent for Braintree Labs drug SUTAB

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for SUTAB
Annual Drug Patent Expirations for SUTAB

Sutab is a drug marketed by Braintree Labs and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

SUTAB drug price trends.

The generic ingredient in SUTAB is magnesium sulfate; potassium chloride; sodium sulfate. One supplier is listed for this compound. Additional details are available on the magnesium sulfate; potassium chloride; sodium sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top